Kiaro Holdings Corp.
Kiaro Holdings Corp.
- Market cap
- $442
Your view on KIARF
Overview
What the company does, where it operates, and who runs it.
About Kiaro Holdings Corp.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- David Jenkins
- Headquarters
- 110 East Cordova Street, Vancouver, BC, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- David Jenkins
- Headquarters
- 110 East Cordova Street, Vancouver, BC, CA
Kiaro Holdings Corp. owns and operates cannabis retail stores in Canada. It operates through three segments: Retail Cannabis Stores, Wholesale Cannabis Business, and eCommerce. The company offers cannabis and cannabis related products.
The company also operates an eCommerce platform that offers consumption accessories in Canada, the United States, and Australia; and engages in the wholesale of cannabis products to other licensed retailers in Saskatchewan.
It sells its products through a network of seventeen stores in British Columbia, Saskatchewan, and Ontario, as well as online. Kiaro Holdings Corp. is headquartered in Vancouver, Canada.
Past Reports
Historical coverage archive.
A Growing Cannabis Retailer Led by Aurora’s Co-Founder – Initiating Coverage
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Kiaro Holdings Corp.. Starting points for Kiaro Holdings Corp.: EPS -$0.42, beta 1.57 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Kiaro Holdings Corp.. Kiaro Holdings Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Kiaro Holdings Corp.. Trailing twelve-month EPS for Kiaro Holdings Corp. stands at -$0.42. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Kiaro Holdings Corp.. Kiaro Holdings Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| RTGNRetinalGenix Technologies Inc. | Healthcare | Medical - Devices | $59.5M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BIEIPremier Biomedical, Inc. | Healthcare | OTC | $599,989 | ||
| BIO.AXBiome Australia Limited | Healthcare | ASX | — | ||
| BIOVFSwedish Orphan Biovitrum AB (publ) | Healthcare | OTC | $12.8B | ||
| BIOYFBioSyent Inc. | Healthcare | OTC | $130.2M | ||
| BJTRFBeijing Tong Ren Tang Chinese Medicine Company Limited | Healthcare | OTC | $542.8M | ||
| BLMSBloomios, Inc. | Healthcare | OTC | $6,447 | ||
| BZYRBurzynski Research Institute, Inc. | Healthcare | OTC | $3.4M | ||
| CBIACanopus BioPharma Incorporated | Healthcare | OTC | $455,071 | ||
| CDXQChina De Xiao Quan Care Group Co., Ltd | Healthcare | OTC | $6,000 | ||
| CELG-RIBristol-Myers Squibb Company Ce | Healthcare | NYSE | $143.2B | ||
| CHMEChina Medicine Corporation | Healthcare | OTC | $829,922 | ||
| CLABFCore One Labs Inc. | Healthcare | OTC | $500 | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Kiaro Holdings Corp., and how their positions are changing. At a $442 market value, institutional positions materially move Kiaro Holdings Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Kiaro Holdings Corp. executives and directors. Shares of Kiaro Holdings Corp. have traded between $0.0000 and $0.0051 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Kiaro Holdings Corp.. Kiaro Holdings Corp. is a $442 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Kiaro Holdings Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Kiaro Holdings Corp.. Coverage tracks Kiaro Holdings Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Kiaro Holdings Corp.